Azurity Pharmaceuticals, Inc. drugs
13 results
Adthyza (levothyroxine and liothyronine)
(Levothyroxine and Liothyronine)Azurity Pharmaceuticals, Inc.
Usage: ADTHYZA™ (thyroid tablets, USP) is indicated for replacement or supplemental therapy in patients with hypothyroidism and as a TSH suppressant for managing goiters, thyroid nodules, Hashimoto's thyroiditis, and thyroid cancer. It is suitable for all ages and states, excluding transient hypothyroidism during subacute thyroiditis recovery.
Adthyza thyroid (levothyroxine and liothyronine)
(Levothyroxine and Liothyronine)Azurity Pharmaceuticals, Inc.
Usage: ADTHYZA (thyroid tablets, USP) is indicated for replacement or supplemental therapy in hypothyroidism of any cause and as a TSH suppressant for managing euthyroid goiters, thyroid nodules, Hashimoto's thyroiditis, multinodular goiter, and thyroid cancer.
Azmiro (testosterone cypionate)
(TESTOSTERONE CYPIONATE)Azurity Pharmaceuticals, Inc.
Usage: AZMIRO is indicated for testosterone replacement therapy in males with conditions causing testosterone deficiency, including primary hypogonadism (e.g., testicular failure, Klinefelter’s syndrome) and hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). The safety and efficacy for age-related hypogonadism and pediatric patients under 12 are not established.
Edarbi (azilsartan kamedoxomil)
(Azilsartan kamedoxomil)Azurity Pharmaceuticals, Inc.
Usage: Edarbi is indicated for the treatment of hypertension in adults to lower blood pressure, thereby reducing the risk of cardiovascular events such as strokes and myocardial infarctions. It can be used alone or in combination with other antihypertensive medications as part of comprehensive cardiovascular risk management.
Epaned (enalapril maleate)
(enalapril maleate)Azurity Pharmaceuticals, Inc.
Usage: EPANED is indicated for the treatment of hypertension in adults and children over one month, reducing blood pressure and cardiovascular event risks. It is also used for symptomatic heart failure, improving survival and reducing hospitalizations, and for clinically stable patients with asymptomatic left ventricular dysfunction, decreasing heart failure development.
Katerzia (amlodipine)
(Amlodipine)Azurity Pharmaceuticals, Inc.
Usage: KATERZIA is indicated for treating hypertension in adults and children (6+ years) to lower blood pressure, reducing cardiovascular event risks. Additionally, it is used for chronic stable angina, vasospastic angina, and to lower hospitalization risk in patients with documented coronary artery disease.
Konvomep (omeprazole and sodium bicarbonate)
(omeprazole and sodium bicarbonate)Azurity Pharmaceuticals, Inc.
Usage: KONVOMEP is indicated for the short-term treatment of active benign gastric ulcers (4 to 8 weeks) and for reducing the risk of upper gastrointestinal bleeding in critically ill adult patients.
Metaraminol bitartrate (metaraminol bitartrate)
(Metaraminol Bitartrate)Azurity Pharmaceuticals, Inc.
Usage: Metaraminol bitartrate injection is indicated for preventing and treating acute hypotension from spinal anesthesia and as an adjunct for hypotension due to hemorrhage, medication reactions, surgical complications, and shock related to brain damage from trauma or tumors.
Nymalize (nimodipine)
(nimodipine)Azurity Pharmaceuticals, Inc.
Usage: NYMALIZE is indicated for improving neurological outcomes by reducing ischemic deficits in adult patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms, applicable to all post-ictus neurological conditions (Hunt and Hess Grades I-V).
Qbrelis (lisinopril)
(lisinopril)Azurity Pharmaceuticals, Inc.
Usage: QBRELIS is indicated for treating hypertension in adults and pediatric patients (6 years and older), reducing the risk of cardiovascular events. It also alleviates symptoms of systolic heart failure and reduces mortality in hemodynamically stable patients post-acute myocardial infarction within 24 hours.